Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.

Cancer Cell Int · 2010 · PMC2878298 · PMID 20433758

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the breast epithelial cell lines, the intensities of the 75 kD nuclear MLL2, indicative of normal proteolytic processing, showed a decreasing trend with increasing malignancy from MCF10A to MDA-MB-231 except for MCF7.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.